uniQure N.V. reported $18M of revenue over the trailing twelve months, −10% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $18M (to Q1 2026). Net income: −$209M, trailing twelve months to Q1 2026. Free cash flow: −$173M, trailing twelve months to Q1 2026. Operating margin: −1104%, trailing twelve months to Q1 2026.

QUREuniQure N.V.

Healthcare

$22.57+63% 1Y

$22.57

$9.0352 weeks$70.59

QURE as reported

uniQure N.V. reported $18M of revenue over the trailing twelve months, −10% on the year before. 10 reported series are charted on this page, each one as filed.

$18M

Revenue, trailing twelve months · to Q1 2026 · −10% against the twelve months before

Net income: −$209M
Net income · −4.0% year on year · trailing twelve months to Q1 2026
Free cash flow: −$173M
Free cash flow · +3.2% year on year · trailing twelve months to Q1 2026
Operating margin: −1104%
Operating margin · trailing twelve months to Q1 2026

Details›

Every series Ryufin has for QURE, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$18M	−10%	Q1 2026
Net income	−$209M	−4.0%	Q1 2026
EPS	−$3.48	−21%	Q1 2026
Gross margin	91%	n/a	Q1 2026
Operating margin	−1104%	n/a	Q1 2026
Net margin	−1265%	n/a	Q1 2026
ROE	1157%	n/a	Q1 2026
ROA	−28%	n/a	Q1 2026
ROIC	−58%	n/a	Q1 2026
Free cash flow	−$173M	+3.2%	Q1 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.